2026 drug pricing debates threaten biotech startups. Learn how small firms can advocate for innovation and survive amidst calls for lower costs.
Aaron Cruz
·
Rupt's 2026 sales strategy aims for a 30% lead boost. Learn how predictive analytics and targeted activations drive early-stage SaaS growth.
·
AbbVie commits $1.2B to Iambic's AI platform for faster drug discovery. See how AI speeds up identifying new therapies, reducing time and cost.
·
Founders: Avoid costly disputes and SEC penalties. Learn 5 key steps for shareholder agreements, compliance, and audits.
·
HANK shows AI's immediate impact on customer service. See how it cuts costs by 25% and boosts satisfaction. Why ignore this change?
·
·
8 min read
How do advocacy groups like Public Citizen challenge big pharma? See 2026's policy changes, including a 15% cost drop for some drugs.
·
·
7 min read
70% of AI chip startups fail by Series B. Find out why, how survivors win with specialization and foundry access, and what's next for AI hardware.
·
·
7 min read
New startups are changing EV battery diagnostics. See how AI monitoring and transparent health reports will affect vehicle lifespan and resale by 2026.
·
·
5 min read
CRISPR AgBio will redefine food security by 2027. Understand how gene editing impacts crops, regulations, and investments in the next five years.
·
·
7 min read
New tech from startups re-architects fuel distribution for 2026. See how AI predicts demand with 90% accuracy & cuts costs.
·
·
7 min read
